Belgium, Aug. 20 -- Belgium based Celltrion Healthcare Netherlands B.V. has secured contract from Cliniques universitaires Saint Luc for Antineoplastic and immunomodulating agents - Infliximab . The value of the contract is worth 2492000 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....